CRGX(Delisted)
CARGO Therapeutics·NASDAQ
--
--(--)
Signals Analysis
Bullish signal 0
Bearish signal 1
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About CRGX
Cargo Therapeutics, Inc.
A clinical-stage biotechnology company developing cancer therapies
835 Industrial Road, Suite 400, San Carlos, California 94070
--
CARGO Therapeutics, Inc., was incorporated in Delaware in December 2019 as Syncopation Life Sciences, Inc., and changed its name to CARGO Therapeutics, Inc., in September 2022. The company is a clinical-stage biotechnology company uniquely positioned to advance the next generation of potential therapeutic cell therapies for cancer patients. The company's programs, platform technologies and manufacturing strategies are designed to directly address the limitations of approved chimeric antigen receptor T cell therapies.
Company Financials
EPS
CRGX has released its 2024 Q3 earnings. EPS was reported at -0.88, versus the expected -1.13, beating expectations. The chart below visualizes how CRGX has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
No Data
You can ask Aime
No Data
